Limin Group Co.,Ltd. (SHE:002734)

China · Delayed Price · Currency is CNY

19.86

-0.46 (-2.26%)

Sep 24, 2026, 3:04 PM CST

Market Cap	9.37B +21.5%
Revenue (ttm)	4.54B +3.4%
Net Income	484.88M +52.3%
EPS	1.07 +40.8%
Shares Out	471.62M
PE Ratio	18.49
Forward PE	16.02
Dividend	0.45 (2.27%)
Ex-Dividend Date	May 22, 2026

Volume	33,715,515
Open	20.32
Previous Close	20.32
Day's Range	19.71 - 21.21
52-Week Range	11.70 - 22.79
Beta	0.82
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 28, 2026

About Limin Group

Limin Group Co.,Ltd. engages in the research and development, production, and sale of fungicides, insecticides, and herbicides in China. The company offers technical, single formulation, and mixture of fungicide, insecticide, herbicide, nematicide, and acaricide. It also provides veterinary drugs, including Azoxystrobin 97% TC, Captan 95% TC, Chlorothalonil 98% TC, Cymoxanil 98% TC, Cyprodinil 95% TC, Difenoconazole 95% TC, Famoxadone 98% TC, Folpet 95% TC, Fosetyl-al 96% TC, Mancozeb 88% TC, Mancozeb 96% TC, Metiram 85% TC, Metiram 87% TC, Met... [Read more]

Industry Agricultural Inputs

Sector Materials

Founded 1996

Employees 4,593

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002734

Full Company Profile

Financial Performance

In 2025, Limin Group's revenue was 4.53 billion, an increase of 6.83% compared to the previous year's 4.24 billion. Earnings were 479.76 million, an increase of 489.70%.

Financial Statements